90556-91-5 Usage
Uses
Used in Pharmaceutical Industry:
2-(4-Aminophenyl)isothiazolidine 1,1-dioxide is used as a potential anti-inflammatory agent for the treatment of inflammatory bowel disease and other inflammatory conditions. Its anti-inflammatory properties make it a promising candidate for further research and development in this area.
Used in Antibacterial Applications:
2-(4-AMinophenyl)isothiazolidine 1,1-dioxide has shown promise as a potential antibacterial agent, particularly against drug-resistant strains of bacteria. This makes it a valuable candidate for the development of new antibiotics to combat the growing issue of antibiotic resistance.
Used in Organic Synthesis:
2-(4-Aminophenyl)isothiazolidine 1,1-dioxide has been investigated for its potential application in the synthesis of pharmaceuticals and other organic compounds. Its unique structure and properties may contribute to the development of new and innovative synthetic pathways for creating valuable compounds.
Further research is needed to fully understand the potential uses and effects of 2-(4-Aminophenyl)isothiazolidine 1,1-dioxide, but its diverse range of potential applications highlights its importance in the ongoing search for new treatments and compounds in the medical and pharmaceutical industries.
Check Digit Verification of cas no
The CAS Registry Mumber 90556-91-5 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 9,0,5,5 and 6 respectively; the second part has 2 digits, 9 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 90556-91:
(7*9)+(6*0)+(5*5)+(4*5)+(3*6)+(2*9)+(1*1)=145
145 % 10 = 5
So 90556-91-5 is a valid CAS Registry Number.
90556-91-5Relevant academic research and scientific papers
NOVEL IMIDAZO-PYRAZINE DERIVATIVES
-
, (2021/12/31)
The invention provides novel imidazo-pyrazine derivatives having the general formula (I), and pharmaceutically acceptable salts thereof, wherein X, m, n, and R1to R3 are as described herein: formula (I). Further provided are pharmace
Discovery, synthesis, and structure-activity relationship development of a series of N -4-(2,5-dioxopyrrolidin-1-yl)phenylpicolinamides (VU0400195, ML182): Characterization of a novel positive allosteric modulator of the metabotropic glutamate receptor 4
Jones, Carrie K.,Engers, Darren W.,Thompson, Analisa D.,Field, Julie R.,Blobaum, Anna L.,Lindsley, Stacey R.,Zhou, Ya,Gogliotti, Rocco D.,Jadhav, Satyawan,Zamorano, Rocio,Bogenpohl, Jim,Smith, Yoland,Morrison, Ryan,Daniels, J. Scott,Weaver, C. David,Conn, P. Jeffrey,Lindsley, Craig W.,Niswender, Colleen M.,Hopkins, Corey R.
, p. 7639 - 7647 (2012/01/05)
There is an increasing amount of literature data showing the positive effects on preclinical antiparkinsonian rodent models with selective positive allosteric modulators of metabotropic glutamate receptor 4 (mGlu4). However, most of the data ge
